Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
04/2003
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases
04/09/2003EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
04/09/2003EP1003758B1 Solution phase synthesis of oligonucleotides
04/08/2003US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors
04/08/2003US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof
04/08/2003US6545038 Heterocyclic metalloprotease inhibitors
04/08/2003CA2275323C Asymmetric synthesis of benzoxazinones
04/03/2003WO2003027084A1 Improved process for the preparation of optically active phenoxazine derivatives as antidiabetic agents
04/03/2003US20030065176 Anticoagulant; cardiovascular disorders
04/03/2003US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/02/2003EP0944609B1 Process for preparing n-alkyl ammonium acetonitrile compounds
04/02/2003EP0873295B1 Dimer-selective rxr modulators and methods for their use
04/02/2003CN1407977A (Hetero) aryl-substituted heterocyclic enaminones, production therof and use thereof as herbicides, acaricides and insecticides
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541471 Useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist
03/2003
03/27/2003WO2003024949A1 Dna-pk inhibitors
03/27/2003WO2003024941A1 Naphthalene compounds and use thereof as drugs
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024401A2 Piperizinones as modulators of chemokine receptor activity
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294700A2 Benzhydryl derivatives
03/25/2003US6538134 Forming by reacting N-benzylethanolamine with glycoxylic acid in solvent; intermediate in synthesis of substance P receptor antagonists
03/25/2003US6538024 Felbamate derived compounds
03/20/2003WO2002085841A3 Substituted catechol derivatives derived from polybasic secondary amino acids, method for production and use thereof
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055076 Novel compounds, their preparation and use
03/19/2003EP1292584A1 Process for the synthesis of (2r, 2-alpha-r, 3a)-2- 1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
03/19/2003EP1292583A1 Process for the synthesis of (2r, 2-alpha-r)-4-benzyl-2- 1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-1,4-oxazin-3-one
03/19/2003EP1292582A1 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
03/18/2003US6534535 Inhibitors of factor Xa
03/13/2003WO2003020709A1 1,2-oxazin-3-one derivatives as antibacterial agents
03/13/2003WO2003020688A1 Selective protein tyrosine phosphatase inhibitors
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003CN1401639A Process for synthesis of azacyclic compounds
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531596 S(-)-2-methoxy-3-(4-(2-(phenoxazin-10-yl)methoxy) phenyl)propionic acid; benzylating p-hydroxybenzaldehyde or tyrosine; reaction with phenoxazinyl mesylate
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/06/2003WO2003018566A1 New piperidinyl derivates as modulators of chemokine receptor activity
03/06/2003WO2003018565A1 Method for synthesizing oxazinones
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/05/2003EP1288205A1 Novel phenylalanine derivatives
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286956A1 Phenyl-substituted 2-enamino-keto nitriles
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/04/2003US6528627 Bridged aromatic substituted amine ligands with donor atoms
03/04/2003US6528507 Arginine salt of 3-(4-(2-(phenoxazin-10-yl)ethoxy) phenyl)-2-ethoxypropanoic acid
02/2003
02/27/2003WO2003016292A1 Ultraviolet light absorbers
02/27/2003WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/27/2003CA2454080A1 Ultraviolet light absorbers
02/26/2003EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
02/26/2003CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias
02/25/2003US6525072 Prevention and treatment of cellular disorders such as cancer
02/25/2003US6525036 Compounds and compositions as protease inhibitors
02/20/2003US20030036558 Useful in the treatment of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor.
02/19/2003EP1283829A1 Method for making acylamides by synthesizing and acylating benzoxazines
02/19/2003CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
02/18/2003WO2002016329A1 Novel phenylalanine derivatives
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/18/2003US6521633 Treating NIDDM with RXR agonists
02/13/2003WO2003011931A1 Use of aromatic polyamines to enhance thermal properties of benzoxazine polymers
02/13/2003WO2003011834A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc
02/13/2003WO2003011298A1 Antibacterial oxazinones and methods for their use and synthesis
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003US20030032635 Heterocyclic esters and amides
02/12/2003EP1283199A1 Melanin-concentrating hormone antagonist
02/12/2003EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
02/12/2003EP1282414A2 Felbamate derived compounds
02/11/2003US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
02/06/2003US20030027821 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
02/06/2003US20030027794 N-heterocyclic derivatives as NOS inhibitors
02/06/2003US20030027238 Optical molecular sensors for cytochrome P450 activity
02/05/2003EP1280784A2 Biologically active 4h-benzo 1,4]oxazin-3-ones
02/05/2003EP1280783A2 Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
02/05/2003EP1280782A2 Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
02/05/2003CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
02/05/2003CN1394855A Substituted heterocyclic compound
02/05/2003CN1100777C N-heterocyclic derivatives as NOS inhibitor
02/05/2003CN1100754C Method for producing trifluoroacetoacetic acid anilides
02/05/2003CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
02/04/2003US6514990 Pharmaceutically active compounds and methods of use
02/04/2003US6514687 Screening a candidate compound for activity as a Cytochrome P450 enzyme substrate by contacting the compound, enzyme, and a reagent chromogen comprising the ether of a phenolic dye such as a coumarin, resofurin or fluorescein dye
01/2003
01/30/2003WO2003008397A1 An improved process for the preparation of antidiabetic phenoxazine compounds
01/30/2003WO2003008396A1 Optically active oxazine derivative
01/30/2003US20030023007 Enhancement of thermal properties of benzoxazine polymers by use of aromatic polyamines to incorporate internal benzoxazine groups within the monomer
01/30/2003US20030022895 2-Amino-benzoxazinones for the treatment of viral infections
01/29/2003EP1278803A2 Sulfonated 8,9]benzophenoxazine dyes and the use of their labelled conjugates
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 112